China (Mainland)
Liraglutide CAS NO 204656-20-2 CAS NO.204656-20-2
- FOB Price: USD: 100.00-200.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T,MoneyGram
- Available Specifications:
API(1-10)GramAPI(10-50)Gramgmp grade(50-100)Gram
- Product Details
Keywords
- Liraglutide
- CAS NO 204656-20-2
- custom peptides
Quick Details
- ProName: Liraglutide CAS NO 204656-20-2
- CasNo: 204656-20-2
- Molecular Formula: C172H265N43O51
- Appearance: white powder
- Application: peptide,custom peptides,cosmetic pepti...
- DeliveryTime: 2 WEEKS
- PackAge: BAG
- Port: SHANGHAI
- ProductionCapacity: 10 Kilogram/Month
- Purity: 99%
- Storage: 2°-8°
- Transportation: Normal transport
- LimitNum: 1 Gram
- Moisture Content: 5%
- Impurity: 2%
- purity: 98%
Superiority
Details
Liraglutide
IN STOCK
QUICK OVERVIEW
Product Name Liraglutide;
Cas No. 204656-20-2;
Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N-ε-(Nα-Palmitoyl-L-γ-glutamyl))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH;
Molecular Formula C172H265N43O51;
Molar Mass 3751.202 g/mol;
Purity ≥98%;
Impurity ≤0.5% ;
Storage Temperature 2-8℃;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.
Function: Liraglutide is for the treatment of diabetes type 2.
Mechanism of actions: Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of heart attack, stroke and CV death in adults with type 2 diabetes and established CV disease.
It was approved by the FDA on December 23, 2014 and by the European Medicines Agency on January 23, 2015, for adults with a body mass index (BMI) of 30 or greater (obesity) or a BMI of 27 or greater (overweight) who have at least one weight-related condition.
Originator Company: Novo Nordisk
Dosage for finished formulation: 18 mg/3ml
Similar effect peptides: Exenatide, Semaglutide
Generic API process in our company: Liraglutide is one of our main peptide projects, related documents will be submitted to the international FDA.